| Q37796017 | Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside |
| Q36326985 | Abnormal network topographies and changes in global activity: absence of a causal relationship |
| Q34160477 | Abnormal regional brain function in Parkinson's disease: truth or fiction? |
| Q33402008 | Abnormal structure-function relationships in hereditary dystonia |
| Q33835425 | Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease |
| Q38254740 | Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease |
| Q24652781 | Cerebellothalamocortical connectivity regulates penetrance in dystonia |
| Q64780329 | Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder |
| Q34770504 | Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease |
| Q40875715 | Dopaminergic correlates of metabolic network activity in Parkinson's disease |
| Q36105698 | Dysfunctional putamen modulation during bimanual finger-to-thumb movement in patients with Parkinson's disease |
| Q64767217 | Effect of levodopa on electroencephalographic biomarkers of the parkinsonian state |
| Q35040119 | Effects of levodopa on regional cerebral metabolism and blood flow |
| Q34035765 | FDG PET in the Evaluation of Parkinson's Disease |
| Q37277039 | Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia |
| Q64265084 | Functional Alteration of Cerebello-Cerebral Coupling in an Experimental Mouse Model of Parkinson's Disease |
| Q34114125 | Functional brain networks and abnormal connectivity in the movement disorders |
| Q34308197 | Functional brain networks in movement disorders: recent advances |
| Q36276626 | Functional imaging in hereditary dystonia |
| Q27013767 | Functional neuroimaging in Parkinson's disease |
| Q34708723 | Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging |
| Q30655192 | Identification of disease-related spatial covariance patterns using neuroimaging data |
| Q38734660 | Imaging synucleinopathies. |
| Q36020017 | Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation |
| Q35012627 | Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. |
| Q33504970 | Metabolic brain networks in neurodegenerative disorders: a functional imaging approach |
| Q36041821 | Metabolic brain networks in translational neurology: concepts and applications |
| Q36198554 | Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease |
| Q37882576 | Milestones in neuroimaging. |
| Q43296929 | Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease |
| Q47632627 | Network Structure and Function in Parkinson's Disease. |
| Q57178629 | Network imaging biomarkers: insights and clinical applications in Parkinson's disease |
| Q33944241 | Network modulation following sham surgery in Parkinson's disease. |
| Q33823530 | Network perspectives on the mechanisms of deep brain stimulation |
| Q24631118 | Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects |
| Q36899657 | Parkinson's disease: increased motor network activity in the absence of movement |
| Q33726349 | Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues |
| Q31041660 | The role of biomarkers and imaging in Parkinson's disease. |
| Q33785397 | Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? |
| Q27024152 | Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? |